{"brief_title": "Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying", "brief_summary": "The purposes of this study are to determine whether an experimental drug known as tadalafil can reduce symptoms of dyspepsia (fullness after eating, inability to finish a regular meal, bloating, discomfort or pain in the upper abdomen, belching after meals, nausea, vomiting) in diabetic patients, and/or reduce the amount of time the stomach takes to empty the contents of a standard meal. The safety of tadalafil given once daily for 8 weeks in this population will also be studied.", "condition": ["Gastroparesis"], "intervention_type": ["Drug", "Drug", "Drug"], "intervention_name": ["tadalafil", "tadalafil", "placebo"], "description": ["5 mg tadalafil tablet taken by mouth once a day for 8 weeks", "20 mg tadalafil tablet taken by mouth once a day for 8 weeks", "Placebo tablet taken by mouth once a day for 8 weeks"], "arm_group_label": ["2", "3", "1"], "other_name": ["LY450190", "Cialis", "IC351", "LY450190", "Cialis", "IC351"], "criteria": "Inclusion Criteria: - Diagnosis of diabetes mellitus - Delayed gastric emptying - 3 month minimum history of chronic upper abdominal discomfort - Symptoms of dyspepsia (upset stomach) Exclusion Criteria: - Major gastrointestinal surgery or medical conditions known to affect gastric motility - Irritable Bowl Syndrome - Medications known to affect gastric motility - Angina treated with nitrates - Uncontrolled diabetes mellitus and history of certain heart problems", "gender": "All", "minimum_age": "18 Years", "maximum_age": "69 Years", "healthy_volunteers": "No", "mesh_term": ["Gastroparesis", "Tadalafil"], "id": "NCT00050609"}